203 related articles for article (PubMed ID: 23527106)
21. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Aliment Pharmacol Ther; 2018 Apr; 47(8):1135-1142. PubMed ID: 29508411
[TBL] [Abstract][Full Text] [Related]
23. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
[TBL] [Abstract][Full Text] [Related]
24. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.
Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 52(1):127-32. PubMed ID: 26967224
[TBL] [Abstract][Full Text] [Related]
26. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland.
Bell SJ; Laitinen ML; Lavikainen P; Lönnroos E; Uosukainen H; Hartikainen S
Pain; 2011 Mar; 152(3):543-547. PubMed ID: 21247697
[TBL] [Abstract][Full Text] [Related]
27. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
[TBL] [Abstract][Full Text] [Related]
28. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
[TBL] [Abstract][Full Text] [Related]
29. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2017; 56(1):119-128. PubMed ID: 27911327
[TBL] [Abstract][Full Text] [Related]
30. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
31. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
32. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
Järvinen H; Tolppanen AM; Hartikainen S
BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
[TBL] [Abstract][Full Text] [Related]
33. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
[TBL] [Abstract][Full Text] [Related]
34. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
Pain; 2017 Feb; 158(2):252-260. PubMed ID: 28092324
[TBL] [Abstract][Full Text] [Related]
35. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
36. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
38. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians.
Weller I; Schatzker J
Ann Epidemiol; 2004 May; 14(5):319-24. PubMed ID: 15177270
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.
Taipale H; Vuorikari H; Tanskanen A; Koponen M; Tiihonen J; Kettunen R; Hartikainen S
Drugs Aging; 2015 Nov; 32(11):937-45. PubMed ID: 26476844
[TBL] [Abstract][Full Text] [Related]
40. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study.
Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Heart Assoc; 2018 Sep; 7(18):e009742. PubMed ID: 30371186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]